VOR
Price:
$0.8048
Market Cap:
$55.05M
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge...[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
VOR
According to Vor Biopharma Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.54. This represents a change of -24.68% compared to the average of 8.68 of the last 4 quarters.
The mean historical Current Ratio of Vor Biopharma Inc. over the last ten years is 9.43. The current 6.54 Current Ratio has changed 6.83% with respect to the historical average. Over the past ten years (40 quarters), VOR's Current Ratio was at its highest in in the March 2021 quarter at 30.85. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
9.43
Median
6.93
Minimum
0.12
Maximum
21.12
Discovering the peaks and valleys of Vor Biopharma Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.76%
Maximum Annual Current Ratio = 21.12
Minimum Annual Increase = -49.94%
Minimum Annual Current Ratio = 0.12
Year | Current Ratio | Change |
---|---|---|
2023 | 9.04 | -49.94% |
2022 | 18.06 | -14.47% |
2021 | 21.12 | 338.93% |
2020 | 4.81 | 39.50% |
2019 | 3.45 | 2.76% |
The current Current Ratio of Vor Biopharma Inc. (VOR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
16.07
5-year avg
11.30
10-year avg
9.43
Vor Biopharma Inc.’s Current Ratio is less than Gracell Biotechnologies Inc. (7.73), less than Theseus Pharmaceuticals, Inc. (29.93), less than Monte Rosa Therapeutics, Inc. (6.56), less than Design Therapeutics, Inc. (41.42), less than Erasca, Inc. (16.79), less than Edgewise Therapeutics, Inc. (30.24), less than Talaris Therapeutics, Inc. (18.64), less than Adicet Bio, Inc. (12.75), less than Cullinan Oncology, Inc. (28.87), less than Nuvalent, Inc. (17.44), less than Ventyx Biosciences, Inc. (14.19), greater than Arcellx, Inc. (6.01), greater than Kiniksa Pharmaceuticals, Ltd. (3.24), greater than Bolt Biotherapeutics, Inc. (4.28), less than Day One Biopharmaceuticals, Inc. (14.62), greater than Lyra Therapeutics, Inc. (3.60), less than Autolus Therapeutics plc (18.50), greater than Foghorn Therapeutics Inc. (5.69), less than Shattuck Labs, Inc. (7.62), less than Kymera Therapeutics, Inc. (8.55), greater than Nurix Therapeutics, Inc. (5.28),
Company | Current Ratio | Market cap |
---|---|---|
7.73 | $989.87M | |
29.93 | $181.50M | |
6.56 | $546.22M | |
41.42 | $294.43M | |
16.79 | $768.41M | |
30.24 | $3.19B | |
18.64 | $116.44M | |
12.75 | $103.00M | |
28.87 | $914.87M | |
17.44 | $6.23B | |
14.19 | $151.94M | |
6.01 | $4.63B | |
3.24 | $1.62B | |
4.28 | $25.20M | |
14.62 | $1.29B | |
3.60 | $16.95M | |
18.50 | $1.11B | |
5.69 | $459.23M | |
7.62 | $59.66M | |
8.55 | $2.96B | |
5.28 | $1.73B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vor Biopharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vor Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Vor Biopharma Inc.'s Current Ratio?
How is the Current Ratio calculated for Vor Biopharma Inc. (VOR)?
What is the highest Current Ratio for Vor Biopharma Inc. (VOR)?
What is the 3-year average Current Ratio for Vor Biopharma Inc. (VOR)?
What is the 5-year average Current Ratio for Vor Biopharma Inc. (VOR)?
How does the current Current Ratio for Vor Biopharma Inc. (VOR) compare to its historical average?